Daniel Ermann

6PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCardiology (incl. cardiovascular diseases)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 30, 2026
Real-world comparative effectiveness of first-line BTK inhibitors in chronic lymphocytic leukemia.

|Jun 24, 2026
Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLL.

|Jan 19, 2024
T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments.

Victoria A Vardell, Daniel A Ermann, Lindsey Fitzgerald

|Apr 20, 2023
Influence of racial and ethnic identity on overall survival in patients with chronic lymphocytic leukemia.

Victoria A Vardell, Daniel A Ermann, Lindsey A Fitzgerald

|Oct 21, 2022
Impact of academic medical center access on outcomes in multiple myeloma.

Victoria A Vardell, Daniel A Ermann, Srinivas K Tantravahi

|Sep 02, 2022
Frontline polatuzumab vedotin for diffuse large B-cell lymphoma: A survey of clinician impressions.

Ajay Major, Edward R Scheffer Cliff, Daniel A Ermann

Pageof 1

Frequent Collaborators

3 joint publications

Victoria A Vardell

2 joint publications

Harsh Shah

2 joint publications

Boyu Hu

1 joint publications

Ajay Major